Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07105202
PHASE4

Shorter Weaning From Invasive Ventilation With Levosimendan

Sponsor: Radboud University Medical Center

View on ClinicalTrials.gov

Summary

Prolonged weaning from mechanical ventilation is a common and serious challenge in the ICU, associated with increased morbidity, mortality, and length of stay. Diaphragm dysfunction plays a key role in weaning failure, and current strategies to support respiratory muscle function are limited. Levosimendan is a calcium sensitizer that enhances cardiac and skeletal muscle contractility, including the diaphragm, without increasing oxygen demand. The investigators hypothesize that treatment with Levosimendan in difficult-to-wean ICU patients will improve diaphragm function and thereby shorten the duration of mechanical ventilation compared to placebo.

Official title: Shorter Weaning From Invasive Ventilation With Levosimendan: a Randomized, Double-blind, Multicentre Study in Critically Ill Patients

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

250

Start Date

2025-09-17

Completion Date

2028-08-01

Last Updated

2026-01-09

Healthy Volunteers

No

Interventions

DRUG

levosimendan

Participants randomized to to the intervention will receive levosimendan. The infusion is administered over 24 hours, starting at a dose of 0.1 µg/kg/min. After 4 hours, the dose may be increased to 0.2 µg/kg/min if tolerated, based on clinical judgment. A maximum of four treatment cycles may be given if the patient is not successfully weaned from mechanical ventilation within 7 days.

DRUG

Soluvit

Participants randomized to this arm will receive a placebo consisting of Soluvit diluted in glucose 5%, administered as an intravenous infusion over 24 hours. The infusion will mimic the Levosimendan administration protocol, starting at 0.1 µg/kg/min and potentially increasing to 0.2 µg/kg/min after 4 hours, to maintain blinding. A maximum of four placebo treatment cycles may be administered if the patient is not successfully weaned from mechanical ventilation within 7 days.

OTHER

Standard care

All patients in this arm will receive standard ICU care, including daily assessments for readiness to wean from invasive ventilation.

Locations (8)

Rijnstate Ziekenhuis Stichting

Arnhem, Gelderland, Netherlands

Intensive Care Medicine, Radboud University

Nijmegen, Gelderland, Netherlands

Canisius Wilhelmina Ziekenhuis

Nijmegen, Gelderland, Netherlands

Jeroen Bosch Ziekenhuis Stichting

's-Hertogenbosch, North Brabant, Netherlands

Catharina Ziekenhuis Stichting

Eindhoven, North Brabant, Netherlands

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Rotterdam, South Holland, Netherlands

Sint Franciscus Vlietland Groep Stichting

Rotterdam, South Holland, Netherlands

Maasstad Ziekenhuis Stichting

Rotterdam, South Holland, Netherlands